bortezomib for injection powder for solution
teva canada limited - bortezomib (bortezomib mannitol boronic ester) - powder for solution - 3.5mg - bortezomib (bortezomib mannitol boronic ester) 3.5mg - antineoplastic agents
bortezomib for injection powder for solution
juno pharmaceuticals corp. - bortezomib (bortezomib mannitol boronic ester) - powder for solution - 3.5mg - bortezomib (bortezomib mannitol boronic ester) 3.5mg - antineoplastic agents
bortezomib for injection powder for solution
juno pharmaceuticals corp. - bortezomib (bortezomib mannitol boronic ester) - powder for solution - 2.5mg - bortezomib (bortezomib mannitol boronic ester) 2.5mg - antineoplastic agents
bortezomib for injection powder for solution
juno pharmaceuticals corp. - bortezomib (bortezomib mannitol boronic ester) - powder for solution - 1mg - bortezomib (bortezomib mannitol boronic ester) 1mg - antineoplastic agents
bortezomib medac 3.5 mg powder for solution for injection
medac gesellschaft für klinische spezialpräparate mbh - bortezomib - powder for solution for injection - 3.5 milligram(s) - other antineoplastic agents; bortezomib
bortezomib 1 mg powder for solution for injection
aspire pharma limited - bortezomib - powder for solution for injection - 1 milligram(s) - other antineoplastic agents; bortezomib
bortezomib 3.5 mg powder for solution for injection
aspire pharma limited - bortezomib - powder for solution for injection - 3.5 milligram(s) - other antineoplastic agents; bortezomib
bortezomib 1 mg powder for solution for injection
european regulatory affairs t/a ivowen - bortezomib - powder for solution for injection - 1 milligram(s) - other antineoplastic agents; bortezomib
bortezomib 3.5 mg powder for solution for injection
european regulatory affairs t/a ivowen - bortezomib - powder for solution for injection - 3.5 milligram(s) - other antineoplastic agents; bortezomib
bortezomib 1 mg powder for solution for injection
morningside healthcare (malta) limited - bortezomib - powder for solution for injection - other antineoplastic agents; bortezomib